A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers
- PMID: 22687521
- DOI: 10.1016/j.neuropharm.2012.05.039
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers
Abstract
Emotional learning is extremely important for the survival of an individual. However, once acquired, emotional associations are not always expressed. The regulation of emotional responses under different environmental conditions is essential for mental health. Indeed, pathologic feelings of fear and anxiety are defining features of many serious psychiatric illness, including post-traumatic stress disorder (PTSD) and specific phobias. The simplest form of regulation of emotional responses is extinction, in which the conditioned response to a stimulus decreases when reinforcement (stimulus) is omitted. In addition to modulating basal anxiety states, recent studies suggest an important role for the endocannabinoid (eCB) and glucocorticoid systems in the modulation of emotional states and extinction of aversive memories in animals. The purpose of this review is to briefly outline the animal models of fear extinction and to describe how these have been used to examine the potential of extinction enhancing agents which specifically alter the eCB and glucocorticoid systems. Pharmacological manipulations of these systems by agents such as cannabinoid or glucocorticoid agonists can enhance the extinction process and avoid the retention of memories which have the potential to trigger trauma. A better understanding of these findings through animal models highlights the possibilities of using combined extinction enhancing agents in exposure-based psychotherapies for anxiety disorders related to inappropriate retention of aversive memories. This article is part of a special issue entitled 'Cognitive Enhancers'.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
[Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders].Psychiatr Pol. 2009 Nov-Dec;43(6):639-53. Psychiatr Pol. 2009. PMID: 20209877 Review. Polish.
-
Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans.Neuropharmacology. 2013 Jan;64:424-31. doi: 10.1016/j.neuropharm.2012.07.045. Epub 2012 Aug 7. Neuropharmacology. 2013. PMID: 22992332 Clinical Trial.
-
The use of cognitive enhancers in animal models of fear extinction.Pharmacol Biochem Behav. 2011 Aug;99(2):217-28. doi: 10.1016/j.pbb.2011.01.009. Epub 2011 Jan 20. Pharmacol Biochem Behav. 2011. PMID: 21256147 Review.
-
Cannabinoid facilitation of fear extinction memory recall in humans.Neuropharmacology. 2013 Jan;64(1):396-402. doi: 10.1016/j.neuropharm.2012.06.063. Epub 2012 Jul 13. Neuropharmacology. 2013. PMID: 22796109 Free PMC article. Clinical Trial.
-
Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications.J Anxiety Disord. 2010 Mar;24(2):223-30. doi: 10.1016/j.janxdis.2009.10.011. Epub 2009 Nov 6. J Anxiety Disord. 2010. PMID: 19962269 Review.
Cited by
-
Psychopharmacologic treatment of borderline personality disorder.Dialogues Clin Neurosci. 2013 Jun;15(2):213-24. doi: 10.31887/DCNS.2013.15.2/lripoll. Dialogues Clin Neurosci. 2013. PMID: 24174895 Free PMC article.
-
Enhance, delete, incept: manipulating hippocampus-dependent memories.Brain Res Bull. 2014 Jun;105(100):2-7. doi: 10.1016/j.brainresbull.2013.12.011. Epub 2014 Jan 4. Brain Res Bull. 2014. PMID: 24397964 Free PMC article. Review.
-
Stress enhances the consolidation of extinction memory in a predictive learning task.Front Behav Neurosci. 2013 Aug 22;7:108. doi: 10.3389/fnbeh.2013.00108. eCollection 2013. Front Behav Neurosci. 2013. PMID: 23986667 Free PMC article.
-
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.Pharmacol Ther. 2015 May;149:150-90. doi: 10.1016/j.pharmthera.2014.12.004. Epub 2014 Dec 27. Pharmacol Ther. 2015. PMID: 25550231 Free PMC article. Review.
-
Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.Neuropsychopharmacology. 2014 Mar;39(4):919-33. doi: 10.1038/npp.2013.292. Epub 2013 Oct 21. Neuropsychopharmacology. 2014. PMID: 24141570 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical